IFN-γ-producing Th17 cells bias by HMGB1-T-bet/RUNX3 axis might contribute to progression of coronary artery atherosclerosis

Atherosclerosis

Volumn 243, Issue 2, 2015, Pages 421-428

  Su, Zhaoliang ^a,b   Lu, Hongxiang ^b   Jiang, Haiqiang ^b,c   Zhu, Haitao ^b   Li, Ze ^d   Zhang, Pan ^b   Ni, Ping ^b   Shen, Huiling ^a   Xu, Wenlin ^a   Xu, Huaxi ^a  

^a The Fourth People's Hospital of Zhenjiang   (China)

^b JIANGSU UNIVERSITY   (China)

^c NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^d Fourth Hospital of Xi'an City   (China)

Author keywords

Atherosclerosis; HMGB1; IFN producing Th17

Indexed keywords

GAMMA INTERFERON; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRANSCRIPTION FACTOR RUNX3; TRANSCRIPTION FACTOR T BET; TRIACYLGLYCEROL; HMGB1 PROTEIN, HUMAN; IFNG PROTEIN, HUMAN; RUNX3 PROTEIN, HUMAN; T BOX TRANSCRIPTION FACTOR; T-BOX TRANSCRIPTION FACTOR TBX21;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL CIRCULATION; PERIPHERAL LYMPHOCYTE; PLAQUE RUPTURE; POLARIZATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TH1 CELL; TH17 CELL; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; BLOOD; CASE CONTROL STUDY; CELL CULTURE; CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; DISEASE COURSE; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; RNA INTERFERENCE; RUPTURE; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 3 SUBUNIT; CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; DISEASE PROGRESSION; FEMALE; HMGB1 PROTEIN; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; RNA INTERFERENCE; RUPTURE, SPONTANEOUS; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; T-BOX DOMAIN PROTEINS; TH17 CELLS; TRANSFECTION;

EID: 84946067979     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.09.037     Document Type: Article

References (35)

1. Lu Y., Chen B., Song J.H., et al. Eriocalyxin B ameliorates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:2258-2263.
2. Murphy C.A., Langrish C.L., Chen Y., et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 2003, 198:1951-1957.
3. Yamashita T., Iwakura T., Matsui K., et al. IL-6-mediated Th17 differentiation through RORgammat is essential for the initiation of experimental autoimmune myocarditis. Cardiovasc Res. 2011, 91:640-648.
4. Hirota K., Duarte J.H., Veldhoen M., et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 2011, 12:255-263.
5. Lee Y.K., Turner H., Maynard C.L., et al. Late developmental plasticity in the T helper 17 lineage. Immunity 2009, 30:92-107.
6. Mukasa R., Balasubramani A., Lee Y.K., et al. Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage. Immunity 2010, 32:616-627.
7. Muranski P., Borman Z.A., Kerkar S.P., et al. Th17 cells are long lived and retain a stem cell-like molecular signature. Immunity 2011, 35:972-985.
8. Ahern P.P., Schiering C., Buonocore S., et al. Interleukin-23 drives intestinal inflammation through direct activity on T cells. Immunity 2010, 33:279-288.
9. Bending D., De la Pena H., Veldhoen M., et al. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J. Clin. Invest 2009, 119:565-572.
10. Annunziato F., Cosmi L., Santarlasci V., et al. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 2007, 204:1849-1861.
11. Dumitriu I.E., Baruah P., Valentinis B., et al. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J. Immunol. 2005, 174:7506-7515.
12. Messmer D., Yang H., Telusma G., et al. High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization. J. Immunol. 2004, 173:307-313.
13. Su Z., Sun C., Zhou C., et al. HMGB1 blockade attenuates experimental autoimmune myocarditis and suppresses Th17-cell expansion. Eur. J. Immunol. 2011, 41:3586-3595.
14. Hori O., Brett J., Slattery T., et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 1995, 270:25752-25761.
15. Ivanov S., Dragoi A.M., Wang X., et al. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood 2007, 110:1970-1981.
16. Park J.S., Svetkauskaite D., He Q., et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 2004, 279:7370-7377.
17. Chen G.Y., Tang J., Zheng P., et al. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Sci. (New York, N. Y. 2009, 323:1722-1725.
18. Dumitriu I.E., Baruah P., Manfredi A.A., et al. HMGB1: guiding immunity from within. Trends Immunol. 2005, 26:381-387.
19. Erlandsson Harris H., Andersson U. Mini-review: the nuclear protein HMGB1 as a proinflammatory mediator. Eur. J. Immunol. 2004, 34:1503-1512.
20. Sims G.P., Rowe D.C., Rietdijk S.T., et al. HMGB1 and RAGE in inflammation and cancer. Annu. Rev. Immunol. 2010, 28:367-388.
21. de Souza A.W., Westra J., Limburg P.C., et al. HMGB1 in vascular diseases: its role in vascular inflammation and atherosclerosis. Autoimmun. Rev. 2012, 11:909-917.
22. Streeck H., Cohen K.W., Jolin J.S., et al. Rapid ex vivo isolation and long-term culture of human Th17 cells. J. Immunol. Methods. 2008, 333:115-125.
23. Fink M.P. Ethyl pyruvate: a novel treatment for sepsis. Curr. Drug Targets. 2007, 8:515-518.
24. Fink M.P. Ringer's ethyl pyruvate solution: a novel resuscitation fluid for the treatment of hemorrhagic shock and sepsis. J. Trauma 2003, 54:S141-S143.
25. Korn T., Bettelli E., Oukka M., et al. IL-17 and Th17 cells. Annu. Rev. Immunol. 2009, 27:485-517.
26. Acosta-Rodriguez E.V., Napolitani G., Lanzavecchia A., et al. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 2007, 8:942-949.
27. Go A.S., Mozaffarian D., Roger V.L., et al. Executive summary: heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014, 129:399-410.
28. Rosenfeld M.E. Inflammation and atherosclerosis: direct versus indirect mechanisms. Curr. Opin. Pharmacol. 2013, 13:154-160.
29. Chen S., Crother T.R., Arditi M. Emerging role of IL-17 in atherosclerosis. J. Innate Immun. 2010, 2:325-333.
30. + T cells in atherosclerosis: regulation by platelets. Thromb. Haemost. 2013, 109:980-990.
31. Galkina E., Ley K. Immune and inflammatory mechanisms of atherosclerosis. Annu. Rev. Immunol. 2009, 27:165-197.
32. Boniface K., Blumenschein W.M., Brovont-Porth K., et al. Human Th17 cells comprise heterogeneous subsets including IFN-gamma-producing cells with distinct properties from the Th1 lineage. J. Immunol. 2010, 185:679-687.
33. Nistala K., Adams S., Cambrook H., et al. Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:14751-14756.
34. Djuretic I.M., Levanon D., Negreanu V., et al. Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells. Nat. Immunol. 2007, 8:145-153.
35. Wang Y., Godec J., Ben-Aissa K., et al. The transcription factors T-bet and Runx are required for the ontogeny of pathogenic interferon-gamma-producing T helper 17 cells. Immunity 2014, 40:355-366.